Infant Oxygen Hoods - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The infant oxygen hoods market size is projected to expand from USD 8.43 million in 2025 and USD 8.83 million in 2026 to USD 11.55 million by 2031, registering a CAGR of 5.53% between 2026 to 2031. This report is Segmented by Product Type (Disposable, Reusable), End User (Level III/IV NICUs, Level II SCBUs, Maternity/Birthing Centers and Pediatric Wards/ER, Home Care/Transport), and Geography (North America, South America, Europe, Asia Pacific, Middle East and Africa). Market Forecasts are Provided in Value (USD Million).

Global Infant Oxygen Hoods Market Trends and Insights

Rising Preterm Births and Neonatal Hypoxemia Burden

Preterm births remain a stable driver of neonatal oxygen needs in high-income markets, with the United States recording a 2024 preterm rate of 10.4%, indicating steady inflows of infants at risk of hypoxemia who require carefully titrated oxygen therapy in early life. Oxygen hoods offer a non-contact alternative for newborns that do not tolerate nasal prongs or CPAP interfaces during short stabilization periods, helping reduce nasal trauma when tissue integrity is fragile. Their utility is bounded by the absence of positive end-expiratory pressure, which limits application to oxygenation support rather than lung recruitment strategies that CPAP provides in surfactant-deficient or atelectatic lungs. Narrow oxygen saturation targets for preterm infants reinforce the need for tight FiO2 control and continuous monitoring, with guidelines emphasizing ranges around 90-95% in extremely low-birth-weight infants to mitigate retinopathy of prematurity and bronchopulmonary dysplasia risk. These clinical parameters preserve a targeted place for oxygen hoods in the infant oxygen hoods market, particularly for brief use cases that do not require positive pressure, while ensuring monitoring and escalation protocols are readily available.

NICU/SNCU Capacity Expansion in Emerging Markets

Government-backed neonatal-care upgrades in Asia and Africa are expanding the installed base for essential respiratory equipment, including oxygen hoods in level II and district facilities where noninvasive positive-pressure systems are not always present. Indonesia’s Sawahlunto Regional General Hospital opened a four-bed NICU and four-bed pediatric ICU in April 2026, funded by Special Allocation Funds totaling Rp 2.4 billion, with integration into SIHREN to strengthen referral alignment and standardize equipment across facilities. A WHO-supported model estimates that low and middle-income countries require 2.8 neonatal beds per 1,000 live births at 85% occupancy, exceeding current capacity in several regions, which raises demand for hygiene-focused consumables as facilities add beds and staff. China’s tiered capability lists specify that county-level units should stabilize moderate acuity cases and deliver CPAP for defined durations before escalation, a framework that also accommodates oxygen hoods for cases where nasal interfaces are not tolerated during initial stabilization. As systems expand, disposable consumables are favored for infection control and fast turnover, while reusable hoods remain present where sterilization workflows are well-managed and operating budgets are tight, positioning the infant oxygen hoods market to serve distinct price and performance tiers across geographies. Funding from multilateral partners, such as the World Bank’s financing to strengthen Nigeria’s primary healthcare network with oxygen access and neonatal resuscitation equipment, further broadens the addressable base for basic respiratory consumables.

Shift to HFNC/CPAP Reducing Routine Hood Use

HFNC and CPAP have become first-line modalities for noninvasive neonatal respiratory support in tertiary environments, limiting oxygen hoods to defined indications such as poor tolerance of nasal interfaces or short stabilization prior to escalation. In a pediatric critical care RCT across 25 U.K. units, HFNC was non-inferior to CPAP for time to liberation from respiratory support, though post-extubation outcomes favored CPAP for key endpoints, reinforcing CPAP’s preferred role when positive-pressure support is a priority. A tertiary-center study comparing bubble CPAP to heated humidified HFNC in neonates reported shorter durations of respiratory support and ventilator days in CPAP cohorts, which strengthens the case for CPAP in acute management where pressure support is crucial. These clinical patterns confine the infant oxygen hoods market to scenarios where passive oxygen delivery suffices and where nasal contact is contraindicated or poorly tolerated, as well as to lower-acuity points of care that lack complex equipment or a respiratory therapist. In this environment, vendors emphasize ease of use and fast setup, while maintaining integration options for escalation pathways that involve CPAP and HFNC within the same care episode.

Other drivers and restraints analyzed in the detailed report include:

• Availability of Disposable Hoods for Infection Control
• Clinical Guidance Formalizing Oxygen Hood Use in Defined Scenarios
• CO2 Retention Risk and Variable FiO2 Without Analyzer

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Disposable oxygen hoods accounted for 45.92% in 2025 and are projected to grow at a 6.57% CAGR through 2031, reflecting infection-control mandates and the operational need for single-patient-use devices during rapid patient turnover in maternity and pediatric units. Reusable hoods held 54.08% of 2025 volume, supported by budget-constrained facilities with established sterilization workflows, although reprocessing complexity and the risk of suboptimal disinfection have led many providers to prioritize disposables in new tenders. The infant oxygen hoods market is seeing greater attention to materials, such as bio-based polymers and plasticizer-free resins, in line with sustainability standards that complement infection-control objectives in high-throughput care areas. Engineering choices that spread gas inlets along the hood surface, along with transparent shells that improve visualization and access for care procedures, have become differentiators as hospitals aim to reduce setup friction in busy delivery suites and pediatric emergency rooms. Infection-prevention policies influenced by COVID-19-era safeguards further entrench disposables in environments with limited sterilization capacity or where staff protection protocols prioritize filtered expiratory pathways and minimized reuse.

Disposable models align with purchasing frameworks that aim to streamline compliance with MDR, ISO 13485, and related quality standards, since single-use devices reduce the burden of validating reprocessing instructions across diverse hospital protocols and equipment fleets. In the infant oxygen hoods market, vendors with broader neonatal respiratory portfolios bundle hoods with CPAP interfaces and ventilator circuits to leverage scale in procurement, an approach that supports education and cross-training for escalation pathways within a single vendor ecosystem. For resource-limited hospitals that maintain effective sterilization departments, reusable hoods remain relevant as a cost-control measure, although recurring labor and quality assurance checks add hidden costs that are increasingly scrutinized in tenders focused on hygiene and turnaround times. On balance, disposables continue to gain share as the infant oxygen hoods market size for disposables is projected to expand in line with infection prevention and sustainability specifications embedded in global procurement standards.

Complete Report Scope:

• By Product Type
  • Disposable oxygen hoods
  • Reusable oxygen hoods
• By End User
  • Level III/IV NICUs (tertiary)
  • Level II SCBUs/step-down units
  • Maternity/birthing centers and pediatric wards/ER
  • Home care/transport use
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South and Central America

Geography Analysis

North America held 46.11% of 2025 revenue, driven by strong adoption of disposables in tertiary NICUs and maternity hospitals, tight infection-control standards, and payment models that accommodate single-use respiratory consumables. The region also sustains baseline demand as the United States preterm rate remained at 10.4% in 2024, which supports the need for supplemental oxygen during early stabilization despite the dominance of HFNC and CPAP in ongoing management. In this environment, hoods are most common when nasal interfaces are contraindicated, during short stabilization periods in labor and delivery, and in rural hospitals that focus on immediate postnatal care prior to transfer. Supply chain sensitivity persists, with some vendors reporting resin and silicone constraints that weighed on device shipments in 2024, underscoring the importance of diversified inputs and inventory buffering in neonatal consumables. As a result, the infant oxygen hoods market continues to track hospital purchasing policies that align hygiene, availability, and ease of use.

Europe’s procurement landscape is shaped by the Medical Device Regulation, which adds cost and time for reapproval of legacy devices and raises evidence expectations for clinical evaluations and post-market surveillance. Vendors with early MDR certification leverage that status to ensure continuity of supply across large hospital networks, including for accessory consumables that complement ventilators and CPAP. Framework agreements that prioritize comprehensive respiratory platforms influence consumable adoption paths, often bundling circuits, interfaces, and compatible hoods to streamline service and training. These dynamics keep oxygen hoods in ancillary roles for defined use cases, while procurement concentrates on multi-modality systems that deliver both positive-pressure support and passive oxygenation. Within this construct, the infant oxygen hoods market share is sustained by facilities that value disposable options for infection control and transparent shells that simplify procedures at the bedside.

Asia Pacific is the fastest-growing region at a 6.24% CAGR, reflecting significant public investment in neonatal beds and tiered capability frameworks that expand care closer to where births occur. Indonesia’s integration of new NICU capacity into its referral network is an example of how standardized procurement, including disposable oxygen hoods, can extend neonatal stabilization capabilities in both urban and rural districts. China’s modified Delphi approach for neonatal units clarifies the scope of county-level care and escalation pathways, which helps define where oxygen hoods fit within stabilization workflows alongside CPAP . In Africa and the Middle East, multilateral financing programs that upgrade primary and referral facilities with oxygen access and neonatal resuscitation equipment expand the addressable base for basic respiratory consumables.

List of Companies Covered in this Report:

• ATEFCO
• Fanem
• Farstar (Wuxi) Medical Equipment
• GaleMed Corporation
• GIGANTE Recem Nascido
• GINEVRI srl
• HEMC Medical
• IndoSurgicals
• JDMeditech
• Medical Dynamics (SuperDome)
• Mercury Medical
• Ningbo David Medical Device
• nice Neotech Medical Systems
• Olidef Medical
• Phoenix Medical Systems
• Plasti-med
• Qingdao Hiprove Medical
• SoCare India
• Utah Medical Products
• VNG Medical

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support